Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Gestational trophoblastic disease (GTD) is a rare condition in which abnormal cells grow inside the uterus after conception. While GTD is primarily diagnosed through imaging and tissue examination, specific blood tests play a crucial supporting role in detection and monitoring of this condition.
This test measures different forms of alkaline phosphatase enzymes in the blood, including placental isoenzymes. Elevated levels of placental alkaline phosphatase isoenzymes can indicate the presence of abnormal placental tissue growth, which is characteristic of gestational trophoblastic disease. This marker helps healthcare providers identify cases that may require additional evaluation and monitoring.
Blood tests are fundamental for supporting the diagnosis of gestational trophoblastic disease by detecting specific markers that can indicate abnormal placental tissue development. These tests help healthcare providers identify potential cases that require further investigation and monitoring.
When placental alkaline phosphatase isoenzymes are elevated, it suggests abnormal trophoblastic tissue activity. This finding, combined with clinical symptoms and other diagnostic methods, helps healthcare providers assess the likelihood of gestational trophoblastic disease and determine appropriate follow-up care.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.